NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Motilal Oswal Maintains Buy Rating on Radico Khaitan

Radico Khaitan (RDCK) has consistently outpaced the industry in terms of growth, resulting in significant market share gains. According to the company's data, Radico Khaitan's market share has grown to approximately 8% of the ~400 million cases in the Indian Made Foreign Liquor (IMFL) market in FY25, with the company selling around 31 million cases.

Radico Khaitan's performance in the premium and above (P&A) segment has been particularly impressive. The company's P&A volumes have expanded from approximately 4 million cases in FY15 to an expected 17 million cases in FY26E. This substantial increase has had a positive impact on Radico Khaitan's earnings profile, with P&A contributing around 70% of the company's IMFL revenues. This figure is expected to increase further, driven by premiumization and operational efficiencies.

In terms of earnings growth, Motilal Oswal expects Radico Khaitan to achieve a compound annual growth rate (CAGR) of approximately 25% in earnings per share (EPS) over the period of FY26-28E. This is considered sufficient to support the company's rich valuations. Based on this growth projection, the research firm values Radico Khaitan at 55 times its FY28E EPS, which translates to a target price of INR3,850. Motilal Oswal has maintained its BUY rating on the stock.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

CompanyP&A Volumes (FY15)P&A Volumes (FY26E)CAGR
Radico Khaitan4 million cases17 million cases23.6%

Note: The CAGR calculation is based on the provided data and may not reflect the actual growth rate.

Investor Takeaway

Investors should consider buying Radico Khaitan stock due to its potential for sustained earnings growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.